Skip to Main Content

John Green, a novelist and high-profile YouTuber, is once again leveraging his star power in the global fight to end tuberculosis. His latest target? The diagnostics company Cepheid and the price of its tuberculosis test, GeneXpert.

Cepheid sells individual test cartridges for $9.98 each, which lab technicians can analyze in a speedy machine that is also sold by the company. But in a scathing YouTube video posted Tuesday, Green argued the price is prohibitive for patients in lower-income countries. Citing an analysis from Doctors without Borders, he noted the tests cost around $4.64 to make. Halve the $10 price tag, Green maintained, and the company can save lives by giving more people access to early detection of TB. Tuberculosis kills 1.5 million people each year, and is most prevalent in countries like India, Indonesia, China, and Nigeria.

advertisement

The controversy isn’t new — Doctors without Borders and other groups have been advocating for a $5 Cepheid test since at least 2019. The organizations also sparred in 2020 over the price of Cepheid’s Covid-19 test. Last year, the advocacy group pushed for the $5 TB test price more strongly in the wake of Cepheid’s waning contract with the World Health Organization. Cepheid dismissed the group’s concerns, calling the cost analysis “flawed” and the demands “unreasonable.”

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.